Showing results (71-80 of 135) with videos related to

Sort By:
Pageof 14
Biochimica Et Biophysica Acta. Reviews on Cancer|May 16, 2026
Emerging concepts, hot topics, and open questions in today's pancreatic cancer researchCorinna Keber, Mark Schmitt, Alexander Visekruna, et al.
Scientific Reports|November 4, 2020
The POLD1<sup>R689W</sup> variant increases the sensitivity of colorectal cancer cells to ATR and CHK1 inhibitorsAlbert Job, Marina Tatura, Cora Schäfer, et al.
NAR Cancer|February 9, 2023
Tumor-suppressive disruption of cancer subtype-associated super enhancer circuits by small molecule treatmentAnke Koeniger, Pierfrancesco Polo, Anna Brichkina, et al.
International Journal of Cancer|April 27, 2018
Therapeutic targeting of tumor-associated macrophages in pancreatic neuroendocrine tumorsSebastian Krug, Rami Abbassi, Heidi Griesmann, et al.
International Journal of Molecular Sciences|October 7, 2020
The Immune Microenvironment in Pancreatic CancerMagdalena Huber, Corinna U Brehm, Thomas M Gress, et al.
Endocrine-Related Cancer|September 25, 2014
CUX1: a modulator of tumour aggressiveness in pancreatic neuroendocrine neoplasmsSebastian Krug, Benjamin Kühnemuth, Heidi Griesmann, et al.
BMC Cancer|November 13, 2021
Ramucirumab in combination with dacarbazine in patients with progressive well-differentiated metastatic pancreatic neuroendocrine tumors (RamuNET): study protocol for a multicenter single-arm trialSebastian Krug, Thomas Kegel, Thomas M Gress, et al.
Gut|October 23, 2010
Stromal biology and therapy in pancreatic cancerAlbrecht Neesse, Patrick Michl, Kristopher K Frese, et al.
Gastroenterology|November 15, 2011
Restricted heterochromatin formation links NFATc2 repressor activity with growth promotion in pancreatic cancerSandra Baumgart, Elisabeth Glesel, Garima Singh, et al.
Cancers|February 13, 2021
Unraveling the Molecular Tumor-Promoting Regulation of Cofilin-1 in Pancreatic CancerSilke D Werle, Julian D Schwab, Marina Tatura, et al.
Pageof 14